WO1998041167A1 - Dispositif permettant une reparation intravasculaire d'un segment de vaisseau sanguin - Google Patents

Dispositif permettant une reparation intravasculaire d'un segment de vaisseau sanguin Download PDF

Info

Publication number
WO1998041167A1
WO1998041167A1 PCT/BE1997/000034 BE9700034W WO9841167A1 WO 1998041167 A1 WO1998041167 A1 WO 1998041167A1 BE 9700034 W BE9700034 W BE 9700034W WO 9841167 A1 WO9841167 A1 WO 9841167A1
Authority
WO
WIPO (PCT)
Prior art keywords
distal
section
occluding
sheath
blood
Prior art date
Application number
PCT/BE1997/000034
Other languages
English (en)
Inventor
Harry Bernard Joseph Spoelstra
Original Assignee
Harry Bernard Joseph Spoelstra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harry Bernard Joseph Spoelstra filed Critical Harry Bernard Joseph Spoelstra
Priority to AU19183/97A priority Critical patent/AU1918397A/en
Priority to JP53995698A priority patent/JP2001514568A/ja
Priority to PCT/BE1997/000034 priority patent/WO1998041167A1/fr
Publication of WO1998041167A1 publication Critical patent/WO1998041167A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2002/065—Y-shaped blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30581—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
    • A61F2002/30583—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid filled with hardenable fluid, e.g. curable in-situ
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0085—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof hardenable in situ, e.g. epoxy resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1011—Multiple balloon catheters

Definitions

  • the present invention relates to an arrangement for the endovascular repair of a biood vessel section, wherein a new blood channel wall is formed in this section.
  • the particular blood vessel section may need repair for various reasons, for example as a result of aneurysmal disease, ruptured aneurysmal disease, occlusive disease (repair needed after dilatation of the occluded section) or blood vessel occlusions of any ethiology, traumatic lesions, AV fistula's, etc.
  • the arrangement according to the present invention may be applicable to all of these disorders, it will be described hereinafter mainly with reference to the repair of a blood vessel aneurysm, in particular an infra- renal abdominal aortic aneurysm.
  • the infrarenal abdominal aorta is prone to aneurysmal dilation between the renal and iliac arteries or even with extension more distally, and is in due course unable to withstand arterial pressures so that dilation tends to progress to a point where rupture is likely.
  • Highly invasive conventional repair such as described in US-A-3,657,744 is a major surgical intervention with high morbidity and even sometimes mortality.
  • the invention is not limited to aortic aneurysm repair and has applications in a variety of situations in which corporeal lumen repair is required.
  • Endovascular repair of abdominal aortic aneurysm avoids much of the morbidity and mortality associated with conventional surgery.
  • endovascular repair techniques disclosed for example in US-A-4,140,126 (Choudhury); US-A-4,512,338 (Balko et al); US-A-4,787,899 (Lazarus); EP-A-0 461 791 (Barone, Parodi, Palmaz); etc., an intraluminal graft/stent is positioned in the aneurysm.
  • This graft/stent is either self-expandable or balloon expandable and is expanded more particularly in a non-dilated part of the blood vessel at the proximal and distal sides of the aneurysm in order to be fixed thereto.
  • Most patients with abdominal aortic aneurysm lack a segment of non- dilated aorta suitable for attachment of the downstream (caudal) end of a straight (single-lumen) endovascular graft. In these patients a more secure outflow is provided by attaching the two caudal ends of a bifurcated graft to the iliac arteries involving however additional problems in correctly positioning and optionally attaching these two caudal ends.
  • a first problem inherent to the know techniques referred to hereinabove is indeed that it is difficult to position the graft accurately in the blood vessel, in particular the upstream end thereof which has to be expanded in the non-dilated aorta segment or neck between the renal arteries and the aortic aneurysm, because the length of this neck is usually rather short and because, once expanded, the graft can no longer be replaced. In case of an incorrect positioning of the graft, a conversion to open surgical repair would thus still be required.
  • a more important problem related to these known techniques is that thrombus formation should occur around the graft in the aneurysm so as to fill or exclude it and so to avoid any flow of blood and thus any blood pressure in the excluded aneurysm since this may still lead to rupture of the aneurysm.
  • this is a very realistic situation in view of the fact that the proximal neck of the aneurysm is usually rather irregular with calcifications and mural trombusmaterial or may in time dilate further creating possible leakage between the wall of the blood vessel and the extremity of the graft expanded therein.
  • Another important problem is the persistence of collateral blood vessels ending in the aneurysm and thus still feeding into the aneurysm with subsequent rupture possibility.
  • a further problem is the existing risk of dislodgement of the graft from the usually short proximal neck of the aneurysm with the further dilatation of this neck.
  • US-A-5, 156,620 discloses also a graft/stent for intraluminal repair of an abdominal aortic aneurysm comprising more particularly a double wall to define a radially expandable chamber along the graft destined to be filled with a plastic material.
  • a drawback of this known graft is that the dimensions thereof have to correspond to the dimensions of the aneurysm so that the aneurysm has to be measured in advance and the graft itself has to be made to size. Of course, this requires additional investigations and time which may be at a premium in case an urgent intervention is required. This is also true for several other stent grafts which are momentarily in clinical use.
  • An object of the present invention is to provide a new arrangement for the endovascular repair of a blood vessel section, in particular an aneurysm or an otherwise damaged or deformed section of a blood vessel, which enables to avoid the drawbacks of the known techniques set forth hereinabove and which especially enables to realise a reliable exclusion of an aneurysm in a relatively easy way.
  • the arrangement according to the present invention is characterized in that it comprises:
  • - means for isolating said section including distal occluding means for occluding the blood vessel at a distal end of said section and proximal occluding means for occluding the blood vessel at a proximal end thereof;
  • a blood channel forming catheter arranged for being inserted into said section to define a blood channel within said section between said proximal and distal occluding means; and - means for injecting an occluding agent producing a solid mass in said section around said blood channel forming catheter to form said new blood wall around said blood channel.
  • the occluding agent is injected in the section, in particular in the aneurysm itself, the solid mass formed upon reaction of the occluding agent will fit accurately therein thus considerably reducing the risks of endoleaks. Moreover, the new blood channel cannot dislodge from the adjacent ends of the blood vessel.
  • An important advantage of the arrangement according to the invention is further that the blood vessel section which has to be repaired has not necessarily to be measured in advance hence enabling a quick intervention, for example in case of rupture of the aneurysm.
  • an important advantage of the arrangement according to the invention is that it does not necessarily require the use of an endograft for repairing the blood vessel.
  • said blood channel forming catheter may, however, be arranged for carrying on its outer surface an endograft, in particular a balloon or self-expandable graft, and for disposing this endograft between said proximal and distal occluding means in said section to form part of the new wall which is to be formed, in particular the inside thereof.
  • the endograft Since the endograft will be embedded in the solid mass formed by reaction of the occluding agent in the aneurysm, it cannot dislodge and its dimensions, especially its width, have not to be adjusted in advance to the dimensions of the aneurysm but the graft can be cut for example to the desired length during the procedure itself when it is clear how long the graft should be.
  • a further important advantage is that even in case the aortic aneurysm extends down to the iliac arteries, no bifurcated graft is required but instead use can simply be made of two grafts which are embedded parallel to one another in the solid mass formed by the occluding agent in the aneurysm.
  • said means for injecting an occluding agent comprise an injection sheath which is insertable through said distal occluding means and which has a lumen arranged to slidably house said blood channel forming catheter.
  • Figures 1 to 3 are partial sectional views of an abdominal aortic aneurysm with extension into the iliac bifurcation illustrating successive steps in the repair of these aneurysms by means of an arrangement according to the present invention
  • Figures 4 and 5 are partial side elevational views, on a larger scale and partly in longitudinal section, of the distal portion of the occlusion catheter of the arrangement shown in Figures 1 and 2 which is inserted upstream through the iliac arteries, respectively in the position shown in these figures, more particularly in a partially and entirely inflated state of the new blood channel forming catheter;
  • Figure 6 is a longitudinal section of the proximal part of the occlusion catheter shown in Figure 5;
  • Figure 7 is a partial side elevational view, also on a larger scale and partly in longitudinal section, of the distal portion of the occlusion catheter of the arrangement shown in Figures 1 and 2 which is inserted downstream in the aorta to occlude the proximal neck of the aneurysm.
  • Figure 8 is a cross-section according to line VIII-VIII in
  • Figure 9 is a longitudinal section of the proximal part of the occlusion catheter shown in Figures 7 and 8;
  • Figures 10 and 11 are views similar to Figures 7 and 8 respectively but relating to an alternative embodiment
  • Figure 12 is a view similar to Figure 4 but relating to an alternative embodiment
  • Figure 13 is a schematic side elevational view of a variant embodiment of the proximal occlusion catheter;
  • Figures 14 and 15 are cross-sectional views through lines
  • Figure 16 is a side elevational view of a variant embodiment of the occlusion balloon of the proximal occlusion catheter shown in Figure 13;
  • Figure 17 is a cross-sectional view according to line XVII-
  • Figure 18 is a schematic side elevational view of a variant embodiment of the distal occlusion catheter
  • Figure 19 is a schematic side elevational view, partly in longitudinal section, of a variant embodiment of the means for injecting the occluding agent
  • Figure 20 is a cross-sectional view through line XX-XX in Figure 18.
  • the arrangement according to a first embodiment of the invention shown in Figures 1 to 9 is usually disposed in the blood vessel by means of a guide wire 1 , in this embodiment even by means of two guide wires 1.
  • How to insert these guide wires 1 in particular through a sub-clavean or brachial artery acess.and down through the aorta 2 and the iliac arteries 3 and out of the left and right femoral arteries, is a technique which is known per se and which will consequently not be described herein in further detail.
  • proximal occluding means are formed by a first occlusion catheter 6, shown on a larger scale in Figures 7-9, and are of a special design, as described hereinafter, in view of occluding the usually short non-dilated proximal part or neck of the aorta 2 without occluding the renal arteries 5.
  • the proximal occluding means or first occlusion catheter 6 comprises a reinforced outer sheath 7, an inner sheath 8, two guide wire tubes or lumens 9 disposed within the inner sheath 8 and a number of inflatable balloon chambers 10, 11.
  • the sheaths 7 and 8 and the tubes 9 are made of a flexible material, such as polyethylene, nylon, polyurethane, polyvinylchloride, teflon, optionally reinforced with a metal mesh to obtain torque.
  • the inner sheath 8 projects out of the outer sheath 7, at least when inserting the catheter 6.
  • the outer sheath 7 can be pulled back over a distance d so that the distal extremity 12 of the inner sheath 8 is released.
  • This distal extremity 12 is either balloon-expandable, balloon-adjustable or even self-expandable and is afixed to the outer balloon 11 in a separate double layer covering and comprises a reinforcement in an inelastic material such as a web like structure of metal or inelastic synthetic fibres or in a foldable material limiting the outward expansion of the more distal portion thereof. This is achieved by the distance of release through the pull back of the outer sheath 7.
  • the limitation of the outward expansion of the distal extremity 12 of the inner sheath 8 is especially important in case of a short neck of non-dilated aorta between the renal arteries 5 and the aneurysm 4 in order to be able to occlude the aorta without occluding the renal arteries 5 and to be able to adjust the diameter to that of the aorta section, more particularly by controlling the length of release of the inner sheath 8 out of the outer sheath 7.
  • the kidneys are indeed very sensitive to an interruption of the blood supply.
  • An important feature of the distal extremity 12 of the inner sheath 8 is further that it is impermeable to blood and that it forms a so- called "umbrella" occlusion structure so that no blood can pass therealong or through.
  • the distal extremity 12 of the inner sheath 8 is self-expandable and balloon-adjustable or balloon- expandable and comprises a soft tip 46.
  • the distal extremity 12, in particular the soft tip 46 is preferably glued or afixed to the balloon used to expand it so that, upon inflation of this balloon, the soft tip bends, whereby the risk of damaging the wall of the blood vessel is considerably reduced.
  • the first occlusion catheter 6, shown in cross-section in Figure 8 comprises at its distal extremity four peripheral balloon chambers 11 , disposed between the guide wire tubes 9 and the distal extremity 12, and one central balloon chamber 10 disposed between both guide wire tubes 9.
  • the peripheral balloon chambers 11 may comprise only two chambers or even only one chamber, preference being given however to four peripheral balloon chambers. These balloon chambers 11 extend either separately through the lumen of the inner sheath 8 to the proximal extremity of the catheter 6 or may be separated from one another, by partition walls 13, only at the distal extremity of the inner sheath 8.
  • the central balloon chamber 10 normally extends separately through the inner sheath 8 and 12 to the proximal extremity thereof and may possibly also be divided by partition walls into two or more balloon chambers.
  • the central balloon chamber 10 serves to spread the distal extremities of the guide wire tubes 9 and is either disposed between these tubes 9 or these latter tubes 9 are attached, in particular glued or welded, within the central balloon chamber 10 to the wall thereof.
  • An important feature of the balloon chambers 10 and 11 is that they project in a non-inflated situation considerably beyond the distal extremity of the guide wire tubes 9 and the edge of the inner sheath 8 and are covered by the outer sheath 7.
  • the balloon chamber 10 and/or the balloon chambers 11 are preferably partially inflated to close off the distal extremity of this catheter 6.
  • these balloon chambers 10 and/or 11 project moreover somewhat out of the outer sheath 7, and are partially inflated, so as to provide a softer balloon tip to make introduction of the catheter easier.
  • the first occlusion catheter 6 for occluding the proximal end of the aneurysm 4 comprises further at its proximal extremity two eyes 14 fixed to a flange 15 on the inner sheath 8 for being able to suture this inner sheath to the body, a flange 16 on the proximal edge of the outer sheath 7 for pulling this outer sheath back over the inner sheath 8, two valve fittings 17, 18 for connecting the inflatable balloon chambers 10, 11 to a source of pressurised fluid, preferably a liquid containing a diluted contrast medium, and two guide wire haemostatic valves 19, 20, mounted on the proximal extremities of the guide wire tubes 9.
  • the blood vessel is also occluded by occluding means, more particularly by a second occlusion catheter 21 to be inserted either in a non-dilated aorta segment at the distal end of the aortic aneurysm, or in case the distal end of the aorta, and possibly also a portion of the iliac arteries, are dilated as shown in Figures 1 to 3, in a non-dilated or non- diseased portion of the iliac or femoral arteries.
  • occlusion catheter 21 in order to isolate the aneurysm 4.
  • Each of the occlusion catheters 21 illustrated on a larger scale in Figures 4-6, comprises a first sheath 22 having at its distal extremity an expandable, inflatable occlusion balloon 23 provided thereon.
  • This occlusion balloon 23 preferably extends right to the edge of the catheter 21 in order to be able to co-operate with the blood channel forming catheter as will be explained hereinafter.
  • the first sheath 22 has a double wall, the annular lumen 24 formed thereby is in fluid communication with the interior of the occlusion balloon 23 and, at the proximal extremity of the sheath 22, with a valve fitting 25 arranged to connect the occlusion balloon 23 to a source of pressurised fluid, preferably a liquid containing a diluted contrast medium.
  • a source of pressurised fluid preferably a liquid containing a diluted contrast medium.
  • the sheath 22 is moreover also provided with an eye 26 for rigidly fixing it by means of sutures to the body of the patient.
  • the central lumen 27 of the first sheath 22 provides a passageway, in particular through a haemostatic valve 61 on the proximal extremity of the sheath 22, for the introduction of means for injecting an occluding agent in the aneurysm 4 in order to form a new blood channel within the aneurysm, more particularly upon reaction of the occluding agent resulting in the formation of a solid mass in the aneurysm.
  • these injection means comprise in particular an injection sheath 28 which is slidably disposed through the central lumen 27 of the first sheath 22 into the aneurysm 4 up to the vicinity of the first occlusion catheter 6.
  • the injection sheath 28 also has a double wall defining an annular lumen 29 for the delivery of the occluding agent into the aneurysm 4. At its proximal extremity, this lumen 29 is connected to an occluding agent inlet port 30. At its distal extremity, four longitudinal rows of occluding agent delivery openings 31 are provided in the outer wall of the injection sheath 28. The diameters of these openings 31 preferably decrease from the distal extremity of the injection sheath 28 towards the proximal extremity thereof in order to make sure the aneurysm 4 will be entirely filled with occluding agent during pull back as explained hereinafter.
  • the injection sheath 28 has a central lumen 32 through which a blood channel forming catheter 33 can be inserted into the aneurysm 4.
  • this catheter 33 is pushed over the guide wire 1 with its distal extremity against the first occlusion catheter 6 to define a new blood channel within the aneurysm 4 between the proximal and distal occluding means.
  • the new blood channel itself will be formed upon reaction of the injected occluding agent to become a solid mass 34 around the blood channel forming catheter 33.
  • the catheter 33 comprises at its proximal extremity a guide wire haemostatic valve 35.
  • the blood channel forming catheter 33 comprises an expandable, inflatable portion, in particular a generally cylindrical balloon 36 which defines, in its expanded state, the new blood channel.
  • the balloon 36 is arranged on a central guide wire tube 37 and extends through the lumen 32 of the injection sheath 28 down to the proximal extremity thereof where it is connected to a valve fitting 38 for connecting the balloon 36 to a source of pressurised fluid, preferable diluted contrast medium, which enables to visualise the balloon 36, or in other words the new blood channel will be formed, under fluoroscopic guidance after balloon expansion.
  • the first or proximal occlusion catheter 6 is first disposed and inflated in the non-dilated proximal neck of the aneurysm 4 in order to occlude this neck without preventing flow of blood into the renal arteries 5. Subsequently, the two distal occlusion catheters 21 are inserted over the guide wires which were delivered through the first occlusion catheter 6, providing a central lumen 27 for the introduction of the injection sheath 28 through which the blood channel forming catheter 33 is then introduced.
  • the blood channel forming catheter 33 is tensed and locked against the first occlusion catheter 6.
  • an occluding agent is injected through the injection sheath 28 into the proximal portion of the aneurysm 4 ( Figure 1 ).
  • the injection sheath 28 is gradually withdrawn during the installation of the occluding agent and through the first sheath 22 whilst the cylindrical balloon 36 of the blood channel forming catheter 33, which remains in place, is simultaneously inflated ( Figure 2).
  • Blood material which is still present in the aneurysm during occlusion agent installation is urged through the space between the first sheath 22 and the injection sheath 28 and through a venting hole 39 connected thereto out of the aneurysm 4.
  • the blood channel forming catheter 33 is shown in an initial state, corresponding to the state in Figure 1 whilst in Figure 5, the catheter 33 is shown nearly in the final state, corresponding to the state shown in Figure 2, wherein the injection sheath 28 has been withdrawn almost completely in the first sheath 22 and the balloon 36 on the catheter 33 is nearly entirely inflated.
  • the balloon 36 When the injection sheath 22 has been withdrawn completely and the balloon 36 on the blood channel forming catheter 33 is entirely inflated, the balloon 36 preferably engages the occlusion balloon 23 in order to obtain a smooth transition between the new blood channel wall which will be formed and the adjacent existing blood vessel wall which did not need repair.
  • the balloons 23 and 36 are deflated and the entire distal occlusion catheters 21 and the proximal occlusion catheter 6, after deflation of balloons 10 and 11 , are removed ( Figure 3). Due to the particular balloon construction of the proximal occlusion catheter 6, a smooth funnel-shaped entrance 40 to the two new blood channels 41 is achieved.
  • aortic endografts 42 which may additionally be used and which have also been illustrated in the figures.
  • the shown aortic endografts 42 comprise at their extremities or over their full length a balloon expandable or selfexpandable stent structure 43.
  • the endografts 42 are initially disposed within the central lumen 32 of the injection sheath 28 over the balloon portion 36 of the blood channel forming catheter 33. When withdrawing the injection sheath 28 whilst injecting the occluding agent, the endografts 42 remain in place and will after balloon dilatation thus define the inner wall of the newly formed blood channels 41 .
  • the same principle is also possible with a full length self-expandable endograft with the need for balloon tayloring after delivery or for a full length balloon expandable graft.
  • the occluding agent is preferably introduced as a liquid and hardens within the aneurysm chamber.
  • the occluding agent may require a reactive catalyst to harden, and the injection sheath may be provided with a further lumen and injection openings adjacent to the first injection openings for separately introducing the catalyst.
  • the occluding agent may react to radiation of a certain wavelength which is provided from an external source and introduced for example through the injection sheath and directed to the injected occluding agent to effect hardening thereof by a light conductor or optical fibre.
  • the occluding agent may comprise a blood coagulating material.
  • EP-A-0 664 104 which are included herein by way of reference.
  • the disclosed occluding agents include more particularly cross-linked collagen implant fibrils which may be mixed with contrast media and chemical buffers of the types described in US-A-4,708,718.
  • a liquid or paste collagen is available under the name HELIOSTAT.
  • a further liquid thrombin mixture is available under the name THROMBOSTAT.
  • Such thrombin and collagen including mixtures form an occluding cast by thrombus formation.
  • liquid, single component, occluding agents described in EP-A-0 664 104 include methyl cyanoacrylate adhesives or 2- hydroxyethyl methylacrylate (HEMA) which set on contact with body fluids, e g of the type described in U S Patent No 4,207,891 directed to occluding Fallopian tubes
  • HEMA 2- hydroxyethyl methylacrylate
  • liquid silicone rubber may be used
  • solid, single component, occluding agents may also be used in solid fibrous or particulate form that may be delivered into the aneurysm to form a solid mass of thrombus The occluding agent is effective to coagulate blood around the fibers or particles and to form the thrombus mass within the aneurysm to function as a solid occluding cast
  • Such occluding agents may also include one of the group of particulate compounds comprising polyvinyl alcohol (PVA), IVALON, and GELL FOAM which are
  • light reactive occluding agents are disclosed in EP- A-0 664 104 including urethane ol ⁇ gomer/(meth) acrylate monomer blends reactive to light in the ultraviolet range and particularly the compound Dymax 136-M which is reactive to ultraviolet light of a frequency of 300-400 nanometers
  • Dymax MD selector guide, Dymax data sheets and the Dymax 10M catalog are described in Dymax MD selector guide, Dymax data sheets and the Dymax 10M catalog
  • proximal occlusion catheter 6 instead of the first proximal occlusion catheter 6 shown in Figures 7 and 8 and comprising two guide wire tubes 9, use can also be made of a proximal occlusion catheter 6 comprising only one guide wire tube It is indeed possible to draw the two guide wires 1 through one and the same guide wire tube but, in view of obtaining a good sealing between the blood channel forming catheters 33 and the proximal occlusion catheter 6 and especially in view of the shape of the finally obtained entrance to the new blood channels 41 , it is preferred to use such a proximal occlusion catheter with one single guide wire tube only in case that only one new blood channel has to be formed, i.e.
  • FIG. 10 and 1 1 A particular embodiment of such a proximal occlusion catheter 6 has been shown in Figures 10 and 1 1 .
  • a central guide wire tube 9 is surrounded by a first tubular balloon 44 which is itself surrounded by a second tubular balloon 45.
  • the outer side of the second balloon 45 is also glued or afixed to the expandable distal extremity 12 of the inner sheath 8, and is impermeable and has moreover a soft tip 46 so as to obtain the desired "bubble” or “pear” shape and to protect against aorta wall damage.
  • a similar "umbrella" occlusion structure is thus obtained as in the embodiment shown in Figures 7 and 8.
  • proximal occlusion catheter 6 By proximal occluding means provided on the blood channel forming catheter 33 itself.
  • a second expandable, inflatable portion or balloon 47 has been provided on the blood channel forming catheter 33, more particularly distally with respect to the first balloon 36.
  • the second balloon 47 has a larger diameter than the first balloon 36 and is arranged to be inflated within the proximal neck of the aneurysm 4.
  • this first balloon 36 is preferably connected through a separate lumen of the blood channel forming catheter 33 to a valve fitting (not shown) so as to enable to inflate the first balloon 36 under a different pressure and separate to that of the second balloon 47.
  • a valve fitting not shown
  • this first balloon 36 may not become stuck in the central lumen 32 of the injection sheath 28 and the inner wall of this injection sheath 28 has not to be reinforced excessively.
  • the first and second balloons 36 and 47 are fixed to one another, in particular through the intermediary of a diaphragm 48 made of a more rigid material In this way, the distal extremity of the first balloon 36 is pulled outwards so as to form also a funnel-shaped entrance to the new blood channel 41 which will be formed in the aneurysm 4
  • the embodiment shown in Figure 12 is especially to be preferred in case blood vessel sections which are not aneurysmal, but which are damaged as a result of for example the intravascular dilatation of a blood vessel occlusion or a trauma such as a bullet or a knife wound or which comprise an AV fistula, are to be repaired
  • the diameter of the second balloon 47 may be larger than the diameter of the first balloon 36 but not necessarily Both diameters may for example be equal
  • the second balloon 47 may even be omitted since it is even possible to occlude the blood vessel at the proximal side of the damaged section by means of the distal portion of the first balloon 36 itself
  • the proximal occlusion means can be inserted also from below and enable moreover to form a double new blood channel within the aneurysm This embodiment may be advantageous in case the upper blood vessels are too narrow or in case a very quick intervention is required
  • the proximal occlusion means comprise an occlusion balloon 50 mounted on a distal extremity of a guide wire tube 51 This occlusion balloon 50 and guide wire tube 51 can be inserted, over a guide wire 1 , upwards through the aneurysm into the non-dilated part of the aorta with or without the use of an additional release sleeve
  • the occlusion balloon 50 defines a funnel- shaped cavity 51 around the distal extremity of the guide wire tube 51
  • a funnel-shaped cavity 52 In the bottom of this funnel-shaped cavity 52, i e at the distal end of the guide wire tube 51 , is provided an opening 53 for the second guide wire 1.
  • a guiding sheath 54 which is introduced over the guide wire tube 51 and shows at its distal extremity a gutter- shaped profile 55 fitting into the funnel-shaped cavity 52.
  • the balloon 50 is connected by means of a diaphragm 56 having an appropriate width to the guide wire tube 51.
  • This diaphragm comprises more particularly a cross-channel (not shown) connecting the interior of the balloon 50 to an inflation lumen provided around the guide wire tube 51 by a sleeve 74 arranged therearound.
  • This sleeve 74 has not been shown in Figures 14 and 15 but only in the variant embodiment shown in Figure 16.
  • the occlusion balloon consists of a first, more elongated balloon 57 surrounded by a second, shorter balloon 58.
  • An advantage of such a double balloon structure is that a more stable structure can be obtained and that the inner balloon can be inflated hereto for example to a higher pressure than the outer balloon.
  • the inner balloon 57 may be provided with a porous, pressure sensitive wall or alternatively, the diaphragm 56 may extend through the inner balloon 57 up to the outer balloon 58, as shown in the cross-sectional view of Figure 17, and may be provided with a further channel for inflating the outer balloon 58. This channel may be connected either by a same or by a different inflation lumen to a source of pressurised fluid, but this has not been shown in the drawings.
  • Figure 18 shows a modification which can be applied to the distal occlusion catheter 21 shown in Figures 4 to 6.
  • the sheath 22 of this occlusion catheter 21 is provided with one or more apertures 59 providing a passageway for the flow of blood material out of the aneurysm 4, between the sheath 22 and the injection sheath 28 (not shown in Figure 18), into the blood vessel distally with respect to the aneurysm 4. In this way, loss of blood can be restricted to a minimum.
  • the occlusion catheter 21 comprises in this embodiment a second sheath 60 which is slidably disposed over the first sheath 22 more particularly between a first position wherein it closes off said aperture(s) 59 and a second position wherein it opens said aperture(s) 59. In its most distal position, it may moreover cover the occlusion balloon 23 itself, for example when inserting the occlusion catheter 21.
  • the second sheath 60 could be provided with aperture(s) corresponding to the aperture(s) in the first sheath 22 and could be mounted in particular rotatably on the first sheath 22 so as to enable to bring the apertures into and out of alignment with one another.
  • the second sheath 60 could also be disposed within the first sheath 22.
  • a possible variant embodiment of the injection means is shown in Figures 19 and 20.
  • the injection sheath 28 is provided with two series of injection openings, namely distal openings 62 for injecting a first occluding agent in the aneurysm 4 and still somewhat more distal openings 63 for injecting a second occluding agent therein.
  • the second occluding agent is more particularly injected within the mass formed by the reacting first occluding agent so that the wall of the newly formed blood channel will consist of two different layers.
  • the injection sheath 28 comprises two occlusion agent delivery lumens 64, 65 each connected to a separate inlet port 66, 67 at the proximal extremity.
  • the injection means illustrated in Figure 19 comprise a motor 68 for rotating the injection sheath 28 around its longitudinal axis, the inlet ports 66, 67 being maintained stationary.
  • the motor 68 may further drive a counter gear wheel 69 screwed on a threaded rod 70 fixed between a flange 71 on the proximal extremity of the occlusion catheter 21 and a flange 72 fixed to flange 71 by means of threaded rod 70 and one or more further rods 73 to which the motor 68 may also be slidably connected.
  • one of the occlusion agent delivery lumens 64, 65 may be arranged to deliver a skeleton material, in particular a supporting wire of a shape memory alloy as disclosed for example in US-A-4,512,338 (Balko et al.) or another synthetic or polymeric substance, around the blood channel forming catheter in the blood vessel section. It is also possible to provide a further lumen therefor in the injection sheath 28.
  • the inserted wire or wires may provide an immediate support and encourage the formation of a solid mass upon contact with the occluding agent. In other words, it enables to deliver an immediate and custom made internally supported endograft.
  • the diameters thereof can be kept to a minimum, especially in case no graft is to be positioned in the aneurysm.
  • the following diameters can for example be applied :
  • Distal occlusion catheter 16-18 FR (5.3-6 mm)
  • radiopaque markers are preferably provided on the different sheaths and on the tips of the guide wire tubes 9 and the blood channel forming catheters 33.
  • the outer surface of the injection sheath 28 is provided with calibrated markers 49 so that, once inserted, the length of the new blood channel which is to be formed can be determined and, just before inserting the blood channel forming catheter 33, the aortic endografts, if used, can be cut to the required length so that no prior measurements have to be done and so that a quick intervention is possible.

Landscapes

  • Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)

Abstract

Cette invention a trait à dispositif ainsi qu'à la technique correspondante permettant une réparation intravasculaire d'un segment de vaisseau sanguin, notamment celle d'un anévrisme de l'aorte abdominale (4). Ce dispositif comprend des organes permettant d'isoler ledit segment, y compris des organes d'obturation distale (6) destinés à obturer l'extrémité distale dudit segment de vaisseau sanguin (2) et des organes d'obturation proximale (21) destinés à obturer l'extrémité proximale dudit segment de vaisseau sanguin (2). Un cathéter (33), constituant un passage sanguin, est inséré dans ce segment définissant ainsi un passage pour le sang entre les organes d'obturation proximale et distale (6, 21). Le dispositif comporte également un organe (28) destiné à l'injection d'un produit obturant donnant lieu à la formation d'une masse solide (34) dans ledit segment autour du passage sanguin, formant ainsi un cathéter (33) constitutif d'une nouvelle paroi autour du passage sanguin.
PCT/BE1997/000034 1997-03-14 1997-03-14 Dispositif permettant une reparation intravasculaire d'un segment de vaisseau sanguin WO1998041167A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU19183/97A AU1918397A (en) 1997-03-14 1997-03-14 Arrangement for the endovascular repair of a blood vessel section
JP53995698A JP2001514568A (ja) 1997-03-14 1997-03-14 血管部分の血管内修復のための装置
PCT/BE1997/000034 WO1998041167A1 (fr) 1997-03-14 1997-03-14 Dispositif permettant une reparation intravasculaire d'un segment de vaisseau sanguin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BE1997/000034 WO1998041167A1 (fr) 1997-03-14 1997-03-14 Dispositif permettant une reparation intravasculaire d'un segment de vaisseau sanguin

Publications (1)

Publication Number Publication Date
WO1998041167A1 true WO1998041167A1 (fr) 1998-09-24

Family

ID=3890264

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BE1997/000034 WO1998041167A1 (fr) 1997-03-14 1997-03-14 Dispositif permettant une reparation intravasculaire d'un segment de vaisseau sanguin

Country Status (3)

Country Link
JP (1) JP2001514568A (fr)
AU (1) AU1918397A (fr)
WO (1) WO1998041167A1 (fr)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021108A1 (fr) * 1999-09-23 2001-03-29 Edwards Lifesciences Corporation Implants destines au traitement des anevrismes
US6383171B1 (en) 1999-10-12 2002-05-07 Allan Will Methods and devices for protecting a passageway in a body when advancing devices through the passageway
US6602280B2 (en) 2000-02-02 2003-08-05 Trivascular, Inc. Delivery system and method for expandable intracorporeal device
US6658288B1 (en) 2000-05-05 2003-12-02 Endovascular Technologies, Inc. Apparatus and method for aiding thrombosis through the application of electric potential
EP2465471A3 (fr) * 2010-12-15 2012-07-18 William A. Cook Australia Pty. Ltd. Dispositif de greffe d'endoprothèse vasculaire
US8252036B2 (en) 2006-07-31 2012-08-28 Syntheon Cardiology, Llc Sealable endovascular implants and methods for their use
US8267989B2 (en) 2004-01-30 2012-09-18 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
WO2013169798A1 (fr) * 2012-05-07 2013-11-14 The Regents Of The University Of California Dilatateur de sphincter œsophagien supérieur
US8758423B2 (en) 2009-06-18 2014-06-24 Graftcraft I Goteborg Ab Device and method for treating ruptured aneurysms
US8864814B2 (en) 2001-12-20 2014-10-21 Trivascular, Inc. Method of delivering advanced endovascular graft and system
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9867727B2 (en) 1998-02-09 2018-01-16 Trivascular, Inc. Endovascular graft
US9907642B2 (en) 2009-07-27 2018-03-06 Endologix, Inc. Stent graft
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
IT201800004093A1 (it) * 2018-03-29 2019-09-29 Bruno Amato Dispositivo vascolare per scleroterapia della vena e metodo
US10849774B2 (en) 2014-10-23 2020-12-01 Trivascular, Inc. Stent graft delivery system with access conduit
US10888414B2 (en) 2019-03-20 2021-01-12 inQB8 Medical Technologies, LLC Aortic dissection implant
CN113578614A (zh) * 2020-04-30 2021-11-02 四川蓝光英诺生物科技股份有限公司 体内管道修复装置和体内管道修复装置的操作方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008289A2 (fr) * 1993-09-16 1995-03-30 Scimed Life Systems, Inc. Reparation percutanee d'anomalies cardio-vasculaires et compositions associees
EP0664104A2 (fr) * 1994-01-24 1995-07-26 Micro Therapeutics, Inc. Cathéter à ballon d'obturation pour anéurismes ou vaisseaux latéraux
WO1997003717A1 (fr) * 1995-07-19 1997-02-06 Endotex Interventional Systems, Inc. Procedes et appareil de traitement des anevrismes
WO1997009008A1 (fr) * 1995-09-08 1997-03-13 Medtronic, Inc. Procedes et appareil permettant d'adapter soudement des protheses dans les lumieres corporelles

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008289A2 (fr) * 1993-09-16 1995-03-30 Scimed Life Systems, Inc. Reparation percutanee d'anomalies cardio-vasculaires et compositions associees
EP0664104A2 (fr) * 1994-01-24 1995-07-26 Micro Therapeutics, Inc. Cathéter à ballon d'obturation pour anéurismes ou vaisseaux latéraux
WO1997003717A1 (fr) * 1995-07-19 1997-02-06 Endotex Interventional Systems, Inc. Procedes et appareil de traitement des anevrismes
WO1997009008A1 (fr) * 1995-09-08 1997-03-13 Medtronic, Inc. Procedes et appareil permettant d'adapter soudement des protheses dans les lumieres corporelles

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10548750B2 (en) 1998-02-09 2020-02-04 Trivascular, Inc. Endovascular graft
US9867727B2 (en) 1998-02-09 2018-01-16 Trivascular, Inc. Endovascular graft
WO2001021108A1 (fr) * 1999-09-23 2001-03-29 Edwards Lifesciences Corporation Implants destines au traitement des anevrismes
US6383171B1 (en) 1999-10-12 2002-05-07 Allan Will Methods and devices for protecting a passageway in a body when advancing devices through the passageway
US6712842B1 (en) 1999-10-12 2004-03-30 Allan Will Methods and devices for lining a blood vessel and opening a narrowed region of a blood vessel
US6602280B2 (en) 2000-02-02 2003-08-05 Trivascular, Inc. Delivery system and method for expandable intracorporeal device
US6658288B1 (en) 2000-05-05 2003-12-02 Endovascular Technologies, Inc. Apparatus and method for aiding thrombosis through the application of electric potential
US8864814B2 (en) 2001-12-20 2014-10-21 Trivascular, Inc. Method of delivering advanced endovascular graft and system
US8267989B2 (en) 2004-01-30 2012-09-18 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
US9138335B2 (en) 2006-07-31 2015-09-22 Syntheon Cardiology, Llc Surgical implant devices and methods for their manufacture and use
US9827125B2 (en) 2006-07-31 2017-11-28 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
US8252036B2 (en) 2006-07-31 2012-08-28 Syntheon Cardiology, Llc Sealable endovascular implants and methods for their use
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US10682222B2 (en) 2007-10-04 2020-06-16 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US12016766B2 (en) 2007-10-04 2024-06-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8758423B2 (en) 2009-06-18 2014-06-24 Graftcraft I Goteborg Ab Device and method for treating ruptured aneurysms
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US10874502B2 (en) 2009-07-27 2020-12-29 Endologix Llc Stent graft
US9907642B2 (en) 2009-07-27 2018-03-06 Endologix, Inc. Stent graft
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP2465471A3 (fr) * 2010-12-15 2012-07-18 William A. Cook Australia Pty. Ltd. Dispositif de greffe d'endoprothèse vasculaire
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
WO2013169798A1 (fr) * 2012-05-07 2013-11-14 The Regents Of The University Of California Dilatateur de sphincter œsophagien supérieur
US11167116B2 (en) 2012-05-07 2021-11-09 The Regents Of The University Of California Upper esophageal sphincter dilator
US10052462B2 (en) 2012-05-07 2018-08-21 The Regents Of The University Of California Upper esophageal sphincter dilator
US10849774B2 (en) 2014-10-23 2020-12-01 Trivascular, Inc. Stent graft delivery system with access conduit
US11752021B2 (en) 2014-10-23 2023-09-12 Trivascular, Inc. Stent graft delivery system with access conduit
IT201800004093A1 (it) * 2018-03-29 2019-09-29 Bruno Amato Dispositivo vascolare per scleroterapia della vena e metodo
US10888414B2 (en) 2019-03-20 2021-01-12 inQB8 Medical Technologies, LLC Aortic dissection implant
CN113578614A (zh) * 2020-04-30 2021-11-02 四川蓝光英诺生物科技股份有限公司 体内管道修复装置和体内管道修复装置的操作方法

Also Published As

Publication number Publication date
JP2001514568A (ja) 2001-09-11
AU1918397A (en) 1998-10-12

Similar Documents

Publication Publication Date Title
WO1998041167A1 (fr) Dispositif permettant une reparation intravasculaire d'un segment de vaisseau sanguin
US7108715B2 (en) Endoluminal graft
US10743979B2 (en) Apparatus and methods for repairing aneurysms
US6706064B1 (en) Expandable device
US20160302798A1 (en) Devices and methods to treat vascular dissections
US7468072B2 (en) Endovascular balloon graft
CA2640263C (fr) Greffon intraluminal gonflable
AU2002302823B2 (en) Devices for repairing aneurysms
EP0664104B1 (fr) Cathéter à ballon d'obturation pour anéurismes ou vaisseaux latéraux
US6478813B1 (en) Method for joining grafts in a common body passageway
US5156620A (en) Intraluminal graft/stent and balloon catheter for insertion thereof
AU678511B2 (en) Aortic graft
EP3834774A1 (fr) Systèmes de greffe d'endoprothèse modulaire comprenant des structures de remplissage gonflables
US20010027338A1 (en) Endovascular device having a stent
AU2002302823A1 (en) Devices for repairing aneurysms
JP3679810B2 (ja) 移植片送達システム
CA2660391A1 (fr) Ballonnet pour element d'endoprothese
AU2002363226B2 (en) Endoluminal graft
AU2002363226A1 (en) Endoluminal graft

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK TJ TM TR TT UA UG US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 539956

Kind code of ref document: A

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase